159 related articles for article (PubMed ID: 2949992)
1. Effect of peptidase inhibitors on [Met5]enkephalin-Arg6-Phe7 and [Met5]enkephalin-Arg6-Gly7-Leu8-induced antinociception.
Mellstrom B; Iadarola MJ; Costa E
Eur J Pharmacol; 1987 Jan; 133(2):185-90. PubMed ID: 2949992
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase.
Mellstrom B; Iadarola MJ; Yang HY; Costa E
J Pharmacol Exp Ther; 1986 Oct; 239(1):174-8. PubMed ID: 2945003
[TBL] [Abstract][Full Text] [Related]
3. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia.
Reggiani A; Carenzi A; Frigeni V; Della Bella D
Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of [Met5]enkephalin and [Met5]enkephalin-Arg6-Gly7-Leu8 in sympathetic and parasympathetic neurons and nerve fibers projecting to the rat submandibular gland.
Soinila J; Häppölä O; Yanaihara N; Soinila S
Neuroscience; 1991; 40(2):545-54. PubMed ID: 1674114
[TBL] [Abstract][Full Text] [Related]
5. The opioid octapeptide Met5-enkephalin-Arg6-Gly7-Leu8: characterization and distribution in rat spinal cord.
Iadarola MJ; Panula P; Majane EA; Yang YT
Brain Res; 1985 Mar; 330(1):127-34. PubMed ID: 3886072
[TBL] [Abstract][Full Text] [Related]
6. Distribution and characterization of the opioid octapeptide met5-enkephalin-arg6-gly7-leu8 in the gastrointestinal tract of the rat.
Wang YN; Lindberg I
Cell Tissue Res; 1986; 244(1):77-85. PubMed ID: 3516403
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
Bünning P
Arzneimittelforschung; 1984; 34(10B):1406-10. PubMed ID: 6097266
[TBL] [Abstract][Full Text] [Related]
8. Comparison of immunohistochemical localization of [Met5] enkephalin-Arg6-Gly7-Leu8, vasoactive intestinal polypeptide and tyrosine hydroxylase in the major pelvic ganglion of the rat.
Karhula T; Soinila S; Häppäolä O
Neuroscience; 1993 May; 54(1):253-61. PubMed ID: 8100047
[TBL] [Abstract][Full Text] [Related]
9. Action of peptidase inhibitors on methionine5-enkephalin-arginine6-phenylalanine7 (YGGFMRF) and methionine5-enkephalin (YGGFM) metabolism and on electroacupuncture antinociception.
Chou J; Tang J; Del Rio J; Yang HY; Costa E
J Pharmacol Exp Ther; 1984 Aug; 230(2):349-52. PubMed ID: 6205138
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Met5-enkephalin-Arg6-Gly7-Leu8-immunoreactive peptides in rat brain: presence of multiple molecular forms.
Lindberg I; Yang HY
Brain Res; 1984 May; 299(1):73-8. PubMed ID: 6722569
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Becker RH; Schölkens BA; Metzger M; Schulze KJ
Arzneimittelforschung; 1984; 34(10B):1411-6. PubMed ID: 6097267
[TBL] [Abstract][Full Text] [Related]
12. Proenkephalin A-derived peptides in the human gut.
Ferri GL; Watkinson A; Dockray GJ
Gastroenterology; 1988 Oct; 95(4):1011-7. PubMed ID: 3410214
[TBL] [Abstract][Full Text] [Related]
13. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor.
Metzger H; Maier R; Sitter C; Stern HO
Arzneimittelforschung; 1984; 34(10B):1402-6. PubMed ID: 6097265
[TBL] [Abstract][Full Text] [Related]
14. Proenkephalin A derivatives in lacrimal gland: occurrence and regulation of lacrimal function.
Cripps MM; Bennett DJ
Exp Eye Res; 1992 Jun; 54(6):829-34. PubMed ID: 1521577
[TBL] [Abstract][Full Text] [Related]
15. The effect of peptidase inhibitors on the release of Met5-Enk-Arg6-Phe7 (YGGFMRF) and Met5-enkephalin (YGGFM) from spinal cord induced by substance P in vivo.
Tang J; Chou J; Yang HY; Costa E
Life Sci; 1983; 33 Suppl 1():121-4. PubMed ID: 6198574
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Schölkens BA; Becker RH; Kaiser J
Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
[TBL] [Abstract][Full Text] [Related]
17. Met5-enkephalin-Arg6-Phe7 inhibition of noradrenaline and acetylcholine release from peripheral organs.
Hársing LG; Rónai AZ; Somogyi GT; Umezawa H; Bajusz S; Vizi ES
J Auton Pharmacol; 1984 Mar; 4(1):33-43. PubMed ID: 6325463
[TBL] [Abstract][Full Text] [Related]
18. Release of proenkephalin-derived opioid peptides from rat striatum in vitro and their rapid degradation.
Patey G; Cupo A; Mazarguil H; Morgat JL; Rossier J
Neuroscience; 1985 Aug; 15(4):1035-44. PubMed ID: 4047398
[TBL] [Abstract][Full Text] [Related]
19. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats.
Unger T; Fleck T; Ganten D; Lang RE; Rettig F
Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269
[TBL] [Abstract][Full Text] [Related]
20. [Met]enkephalin-Arg6-Gly7-Leu8-immunoreactive nerves in guinea-pig and rat lungs: distribution, origin, and co-existence with vasoactive intestinal polypeptide immunoreactivity.
Shimosegawa T; Foda HD; Said SI
Neuroscience; 1990; 36(3):737-50. PubMed ID: 1700333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
